Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 88,211 shares at $29.27 ($2.6M) on 2016-07-05, disclosed to the SEC on 2016-07-07.
Open-market sale of $2.6M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.27 | 49,871 | $1.5M | 56.2% |
| 2 | $29.96 | 2,905 | $87K | 3.4% |
| 3 | $29.27 | 9,900 | $290K | 11.2% |
| 4 | $29.80 | 25,535 | $761K | 29.3% |
| Total | $29.45 avg | 88,211 | $2.6M | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |